ACC.24: The STEP HFpEF DM Trial
![](https://i.ytimg.com/vi/kvqRrhAOl7s/mqdefault.jpg)
17:18
Insights from STEP-HFpEF Trial | ESC Heart Failure 2024
![](https://i.ytimg.com/vi/-n6V6ccd3-8/mqdefault.jpg)
13:25
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial
![](https://i.ytimg.com/vi/ymmjg-aENtE/mqdefault.jpg)
17:29
ESC 24 Hot Line Discussion: The FINEARTS-HF Trial
![](https://i.ytimg.com/vi/2vHoZe7zVcs/mqdefault.jpg)
15:54
Semaglutide Benefits in HFpEF Take a Step Beyond Weight Loss
![](https://i.ytimg.com/vi/1G-UYK7iN0c/mqdefault.jpg)
1:02:01
Dr. Mikhail Kosiborod: "The Most Vexing of Cardiotoxicities: Diabetes and Heart Failure"
![](https://i.ytimg.com/vi/uKj2H4bgdYI/mqdefault.jpg)
5:23
STEP HFpEF DM Trial Whiteboard - Canadian Perspectives on the ACC 2024
![](https://i.ytimg.com/vi/89_9c9RVQ6U/mqdefault.jpg)
49:31
SUMMIT 2024: A Masterclass Video Interview with Harlan Krumholz and Milton Packer | JACC | AHA 2024
![](https://i.ytimg.com/vi/RJL28lKbiAA/mqdefault.jpg)
20:11